Cao Pharmaceuticals, NanoMaterials deal

Cao granted NanoMaterials’ NMT Pharmaceuticals Pte. Ltd. subsidiary exclusive, worldwide rights to develop and commercialize cancer candidate CZ-48. The analog of camptothecin, a topoisomerase ( TOP...